Allergy & Immunology
RCT | Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis.
20 Sep, 2022 | 13:20h | UTCCommentary: Dupilumab Eases Atopic Dermatitis in Children Younger Than 6 Years – HealthDay
Guideline Summary | Management of patients with suspected or confirmed antibiotic allergy.
8 Sep, 2022 | 14:42h | UTCRelated:
M-A: Most patients with allergy to Penicillin can be given Cefazolin
Podcast: A Clinical Pharmacologist’s Perspective on Penicillin Allergy
Study: Development and Validation of a Penicillin Allergy Clinical Decision Rule
NICE: Double Check Patients with ‘Penicillin Allergy’ to Avoid Increased MRSA Risk
European guideline (EuroGuiDerm) on atopic eczema – Part II | Non-systemic treatments and treatment recommendations for special AE patient populations.
5 Sep, 2022 | 14:32h | UTC
Guideline | Management of kidney transplant patients with HLA antibodies.
31 Aug, 2022 | 11:47h | UTC
Clinical practice guidelines for the management of atopic dermatitis.
24 Aug, 2022 | 14:13h | UTC
European guideline on atopic eczema – Part I: systemic therapy.
19 Aug, 2022 | 16:14h | UTC
Review | Plasma exchange in the intensive care unit.
15 Aug, 2022 | 12:19h | UTCPlasma exchange in the intensive care unit: a narrative review – Intensive Care Medicine
Commentary on Twitter
Therapeutic plasma exchange in #ICU
? indications for urgent TPE
? mechanisms, kinetics and therapeutic goals
? diagnostic workup & monitoring
? technical aspects
? clinical response & complications
? unanswered questions & research agenda#FOAMcc
? https://t.co/CojkcA81Dy pic.twitter.com/MsAdjgJhNL— Intensive Care Medicine (@yourICM) August 13, 2022
M-A | Interventions to reduce infections in patients with hematological malignancies.
15 Aug, 2022 | 11:51h | UTCCommentary: Prophylactic Immunoglobulin, Vaccinations May Reduce Infections in Hematologic Malignancies – AJMC
Consensus Statement | Pharmacological management of allergic rhinitis.
11 Aug, 2022 | 12:10h | UTCRelated:
Guideline | Management of immunoglobulin replacement therapy.
5 Aug, 2022 | 14:35h | UTC
M-A | Treating eosinophilic esophagitis with budesonide.
27 Jul, 2022 | 12:06h | UTC
RCT | Efficacy and safety of Abrocitinib vs. Dupilumab in adults with moderate-to-severe atopic dermatitis.
25 Jul, 2022 | 12:44h | UTCEfficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial – The Lancet (link to abstract – $ for full-text)
Related: Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis – New England Journal of Medicine
Systematic Review | Anti‐IL‐5 therapies for asthma.
14 Jul, 2022 | 12:40h | UTCAnti‐IL‐5 therapies for asthma – Cochrane Library
M-A | Prenatal antibiotic exposure, asthma, and the atopic march.
8 Jul, 2022 | 11:31h | UTC
Review | Cough hypersensitivity and chronic cough.
4 Jul, 2022 | 12:59h | UTCCough hypersensitivity and chronic cough – Nature Reviews Disease Primers (if the link is paywalled, try this one)
See also: Infographic (if the link is paywalled, try this one)
Commentary on Twitter
#Cough is mediated by a complex set of neurobiological processes involving the peripheral nervous system, brainstem and higher brain. #ChronicCoughhttps://t.co/DGgjk2Iyji pic.twitter.com/nrmJne7Ir8
— Nature Reviews Disease Primers (@DiseasePrimers) July 2, 2022
Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug.
4 Jul, 2022 | 12:57h | UTCBad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug – Science
See also: SARS-CoV-2 can evade Paxlovid by multiple mechanisms – News Medical
Opinion | FDA: Don’t rush a move to change the Covid-19 vaccine composition.
4 Jul, 2022 | 12:53h | UTCFDA: Don’t rush a move to change the Covid-19 vaccine composition – STAT
Antibodies to combat viral infections: development strategies and progress.
4 Jul, 2022 | 12:51h | UTCAntibodies to combat viral infections: development strategies and progress – Nature Reviews Drug Discovery (if the link is paywalled, try this one in PMC)
Consensus for the definition, classification, diagnosis, and management of urticaria.
1 Jul, 2022 | 11:32h | UTC
Survey: The multidimensional burden of atopic dermatitis among adults.
30 Jun, 2022 | 10:57h | UTC
RCT: A 2-week interruption in methotrexate treatment doubles the antibody response to a COVID-19 booster vaccine.
29 Jun, 2022 | 12:10h | UTCNews Releases:
Interrupting immune-suppressing treatment can boost COVID vaccine response – Imperial College London
Commentaries:
Commentary on Twitter
NEW Research—2-week interruption of methotrexate treatment for people w/ immune-mediated inflammatory diseases = enhanced boosting of antibody responses after #COVID19 vaccination
From Prof Abhishek Abhishek & colleagues https://t.co/y14pUEaB5X pic.twitter.com/pLvaXjJzoz
— The Lancet Respiratory Medicine (@LancetRespirMed) June 28, 2022
Guideline for the emergency management of anaphylaxis.
28 Jun, 2022 | 10:59h | UTCRelated:
EAACI guidelines: Anaphylaxis (2021 update) – European Journal of Allergy and Immunology
Review: Management of moderate-severe atopic dermatitis in pediatric age.
27 Jun, 2022 | 11:32h | UTC
Analysis of 7 RCTs: Dupilumab treatment reduces hospitalizations in adults with moderate-to-severe atopic dermatitis.
27 Jun, 2022 | 10:56h | UTCCommentary: Treatment Reduces, Exterminates Hospitalizations in Adults With Moderate to Severe AD – Consultant360
Commentary on Twitter
In Current Issue! #Dupilumab Treatment Reduces #Hospitalizations in #Adults With #Moderate– #to– #Severe #Atopic #Dermatitis https://t.co/eYqy95FADb pic.twitter.com/pRaVh9tw4S
— JACI In Practice (@JACIInPractice) May 10, 2022
EULAR/ACR points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases.
24 Jun, 2022 | 11:23h | UTC